Skip to main content
. 2021 Nov 23;42(1):49–62. doi: 10.1161/ATVBAHA.121.317113

Figure 5.

Figure 5.

Correlation of S100A8/A9 in platelet-poor plasma with clinical variables and light transmission aggregometry measurements in a community-based cohort study. A, Correlation of S100A8/A9 levels in platelet-poor plasma with clinical variables (n=338). B and C, Correlation of S100A8/A9 levels in platelet-poor plasma with light transmission aggregometry (LTA) measurements in nonaspirin users (B; n=185) and aspirin users (C; n=153).